Publications by authors named "F Lisovoski"

Assessment programs recently designed to follow-up patients with Huntington's disease (HD) in therapeutic trials have not included electrophysiological testing in the list of mandatory examinations. This omission is likely due to the current lack of data establishing a clear correlation between the electrophysiological results and those of clinical assessment. We address this issue in a cohort of 36 patients at relatively early stages of the disease (I and II).

View Article and Find Full Text PDF

Ciliary neurotrophic factor (CNTF) is a potent protective factor for striatal neurons in animal models of Huntington's disease (HD). Clinical application of this potential therapeutic still requires the design and optimization of delivery systems. In the case of HD, spatial spread in the vast volume occupied by the striatum and long-term delivery of the factor are particular challenges for these systems.

View Article and Find Full Text PDF

Diffuse invasion of the brain by tumor cells is a hallmark of human glioblastomas and a major cause for the poor prognosis of these tumors. This phenomenon is only partially reproduced by rodent models of gliomas that display a very high rate of proliferation and limited cell migration. We have analyzed the development of human glioblastoma cells (GL15) xenografted into the brain of immunosuppressed rats, in order to define the characteristics of tumor cell invasion.

View Article and Find Full Text PDF

Hypertrophic neuropathy is a peripheral nerve lesion that is histologically characterized by onion bulb formations around axons. This histologic picture, which is usually seen in generalized hypertrophic neuropathies, can occasionally be observed in single nerves as localized hypertrophic neuropathy. Cranial involvement of such localized hypertrophic neuropathy represents a very rare entity; only a few cases have been reported in the literature.

View Article and Find Full Text PDF
Article Synopsis
  • Huntington's disease is a genetic neurodegenerative condition that affects motor and cognitive functions, currently without a cure; this study investigated the effects of fetal striatal neuroblast transplantation in patients.
  • Five patients with mild to moderate Huntington’s disease underwent grafts with human fetal neuroblasts in both striata, with assessments after one year revealing increased metabolic activity in some patients compared to untreated controls.
  • Three out of the five patients showed functional improvements in motor and cognitive abilities, indicating that fetal neural grafts may provide a potential therapeutic approach for managing Huntington's disease symptoms.
View Article and Find Full Text PDF